SCHEMBL6901844

SCHEMBL6901844

O=C(NC1CCN(Sc2ccc([N+](=O)[O-])cc2)CC1)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.53
CTSB P07858 1/20 0.53
CTSK P43235 1/20 0.53
ALDH1A1 P00352 1/20 0.51
GAA P10253 1/20 0.51
SIGMAR1 Q99720 4/20 0.51
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
GPR55 Q9Y2T6 2/20 0.49
TSHR P16473 1/20 0.49
EPHX1 P07099 2/20 0.47
DPP4 P27487 1/20 0.46
KCNH2 Q12809 1/20 0.46
DPP7 Q9UHL4 1/20 0.46
F13A1 P00488 1/20 0.46
TGM2 P21980 1/20 0.46
TGM1 P22735 1/20 0.46
HSD11B1 P28845 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6901870 0.86 CTSL (0.57) CTSLCTSBCTSKALDH1A1GAA
SCHEMBL1871194 0.82 TGM2 (0.67) CTSLCTSBCTSKALDH1A1GAA
SCHEMBL6901859 0.81 KMT2A (0.50) ALDH1A1MEN1KMT2A
Nitrobenzene SCHEMBL28019505 0.80 EPHX1 (0.67) ALDH1A1GAAMEN1KMT2ATSHR
SCHEMBL6902881 0.79 TGM2 (0.69) CTSLCTSBCTSKALDH1A1GAA
SCHEMBL21227845 0.79 SIGMAR1 (0.53) SIGMAR1MEN1KMT2AHSD11B1
SCHEMBL6901635 0.78 SMN1; SMN2 (0.52) SIGMAR1MEN1KMT2AF13A1TGM2
SCHEMBL2199000 0.77 EPHX1 (0.72) ALDH1A1GAAMEN1KMT2AEPHX1
SCHEMBL30981394 0.76 SIGMAR1 (0.52) CTSLCTSBCTSKALDH1A1GAA
SCHEMBL20590829 0.76 ALDH1A1 (0.55) ALDH1A1GAASIGMAR1TSHREPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011060321-A1 TRANSGLUTAMINASE TG2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF CHDI, INC. (US) 2011-05-19 WO disclosed